Study at a glance
What did studies examine about vitamin D and the brain?
Three studies examined how vitamin D might act in the brain. One examined brain tissue from five men after death. Two tested calcitriol, the active vitamin D hormone, in laboratory nerve-cell models. These included altered human tumour cells and developing rat cells or tissue.
Where were vitamin D receptors found in the brain?
The researchers located vitamin D receptors, which respond to calcitriol, and an enzyme that helps make active vitamin D. Their locations differed between brain regions. This showed possible sites of action, not how well those brain regions worked.
How did active vitamin D affect nerve-cell growth and signals?
Calcitriol lengthened nerve-cell extensions in the altered human cells, but growth effects differed between the models. These human cells also contained more dopamine, a chemical messenger, with more measured in the surrounding liquid. A test using a fluorescent signal suggested changes in release from small storage compartments after longer exposure. This was an indirect test, not a direct measurement of normal communication between nerve cells.
Did calcitriol protect nerve cells?
In a separate study, developing rat nerve cells survived some laboratory challenges better at lower tested calcitriol concentrations. The highest tested concentrations did not protect the cells. These were laboratory exposures, not supplement doses for people.
Do the results show a brain-health benefit for people?
No benefit for brain health was established. Small samples and specially prepared cells limit what these results can tell us about a living human brain. The studies do not show that supplements improve brain development, preserve memory or prevent brain disease.
Read the full article below ↓How can vitamin D signalling be relevant to brain development, the maintenance of neurons and regional brain function? Three primary papers approach different parts of that question: human tissue mapping, developing dopamine-cell models and calcium regulation in cultured hippocampal neurons. Together they support biological plausibility, while leaving clinical benefit and many causal steps unresolved. For the shorter account, read Vitamin D Signalling in Brain Development and Regional Function: Study Summary.
Three kinds of evidence with different meanings
The brain overview introduces the wider physiological context. This appraisal focuses on what experimental methods can establish about local signalling. Finding a receptor in a brain region identifies a potential response system. Changing a developing cell in a dish demonstrates a response under controlled conditions. Neither result, by itself, measures learning, executive performance or protection from disease in a living person.
Vitamin D receptors, usually abbreviated VDR, respond to calcitriol, the active vitamin D hormone. Receptor-related effects depend on the cell, its developmental stage and the surrounding conditions. A precursor supplied orally is not the same exposure as calcitriol added directly to culture medium. The receptor framework therefore helps organise these papers without assuming that a blood concentration, a culture concentration and a tissue response are interchangeable.
Human tissue mapping: where a response system may exist
Eyles and colleagues examined postmortem brain tissue from five men aged 34 to 58 years. They used antibody staining to locate VDR and 1-alpha-hydroxylase, an enzyme involved in generating active vitamin D. Staining varied between regions and cell populations, with prominent findings in the hypothalamus and substantia nigra. The hippocampus, a region involved in learning and memory, provides a more detailed example: receptor staining in its pyramidal nerve cells was stronger in the CA1 and CA2 subdivisions than in CA3, whereas enzyme staining was more evenly distributed across these subdivisions. The receptor and the activating enzyme therefore did not always share the same local pattern. These observations locate a potential signalling system; they do not measure the performance of those regions.
The measurements were largely qualitative staining assessments. Two observers agreed closely, but antibody signal is not a direct assay of enzyme activity or local hormone production. The small, male-only postmortem sample, fixation history and interval after death limit generalisation. The study did not compare cognitive performance or establish how circulating vitamin D related to the tissue findings. Its map should guide questions, not be read as a map of proven clinical benefits.
Regional localisation creates a useful hypothesis about neuroendocrine integration. A receptor in a region involved in physiological regulation may permit local hormonal effects, but the location alone does not identify which feedback loop changes or whether that change improves function. A convincing functional experiment must measure the relevant output and distinguish a direct local action from effects elsewhere in the body.
Developing dopamine-cell models: the central experimental paper
Pertile and colleagues studied three complementary preparations in 2023: a human neuroblastoma cell line engineered to express VDR, primary rat embryonic midbrain cultures, and paired midbrain-striatal tissue explants. Neuroblastoma cells are tumour-derived cells used here as a laboratory model, not ordinary human brain tissue. Primary cultures contain cells taken directly from developing tissue, while explants retain small pieces of tissue. These preparations preserve different features of neural development, but they remain related models within one laboratory study rather than independent demonstrations in people.
The engineered SH-SY5Y cells underwent retinoic-acid differentiation, a laboratory procedure encouraging a more mature nerve-like form, before exposure to 20 nanomolar calcitriol. Nanomolar means billionths of a mole per litre and describes the concentration in the culture medium. The cells expressed an introduced rat receptor, which matters when judging their resemblance to ordinary human neurons. The primary midbrain cultures came from embryonic-day-14.5 rats and received calcitriol during maturation. Placing midbrain and striatal explants close together allowed the researchers to assess processes growing toward a target tissue over forty-eight hours.
The investigators measured neurites, the extensions through which developing neurons establish their shape and contacts. They also examined markers associated with synaptic vesicles, measured dopamine chemically and tested a fluorescent reporter of vesicle release. These endpoints extend beyond receptor staining. However, they still represent selected components of neural development and function rather than a complete circuit with normal sensory inputs, learning and behaviour.
Growth effects were not uniform across preparations
Calcitriol increased neurite length in the engineered cell model. In the primary midbrain cultures, overall neurite length and total branching did not increase significantly. A distance-based analysis found a change in branching pattern, which is a different result from a general increase in all branches. The explant experiments supported increased growth of selected neurites. Preserving these distinctions avoids turning a mixed set of morphology findings into a uniform growth claim.
The morphology analyses included small numbers of cultures with multiple cells or processes sampled from them. For example, the engineered-cell comparison involved approximately twenty-five to thirty-one cells per condition from three cultures; primary-culture analyses included twelve cells from three cultures. Measurements from cells sharing a preparation may be correlated. The number of traced cells should not be presented as the number of independent animals or independent replications.
Selection rules also shape interpretation. Morphology was assessed blind, but the explant analysis examined the ten longest neurites from each of three co-cultures. That endpoint asks about the most extended processes, not the average behaviour of every developing axon. Blinding reduces one source of bias; it does not remove limitations from sampling choices, model construction or the small number of separate preparations.
Dopamine handling and vesicle-associated markers
The study found increases in dopamine inside cells and in the culture medium in the engineered-cell model. It used high-performance liquid chromatography, a chemical separation method that allows dopamine to be measured. Dopamine in the medium could also reflect leakage; that measurement alone did not establish regulated release. The study also reported changes in transcripts, the RNA messages copied from genes, for tyrosine hydroxylase and monoamine oxidase A, enzymes involved in dopamine synthesis and metabolism. These findings are relevant to gene expression, but an RNA message, enzyme activity and net transmitter availability are different measurements.
The researchers also stained proteins associated with synaptic vesicles, the small compartments used to store and release chemical transmitters. These included synaptic vesicle glycoprotein 2C, or SV2C, a vesicle-membrane protein studied in relation to dopamine release, and synaptophysin, another vesicle-associated marker. The calcitriol-treated cells had approximately twice as many puncta, the small fluorescent spots defined by image analysis, for both markers as the solvent-only and retinoic-acid comparison groups; the reported comparisons were P<0.001. The solvent-only group is the study’s vehicle control. SV2C staining intensity nevertheless decreased, while synaptophysin intensity did not differ significantly from vehicle. More spots and brighter spots are different findings, and neither alone proves more functional connections between neurons.
The release experiment used FFN200, a fluorescent false neurotransmitter, in the engineered SH-SY5Y/VDR-positive cells. Cells take up this fluorescent probe, which is used to follow release associated with transmitter-storage vesicles. Loss of its fluorescence after stimulation provides an indirect release readout. After seven days of calcitriol exposure during maturation, amphetamine-induced fluorescence decay was faster: approximately minus 2.25% per minute with calcitriol and minus 0.66% with the solvent-only vehicle. A separate photobleaching control, which measured fading under illumination without the release stimulus, declined by about 0.38% per minute.
The three measurements came from eight calcitriol-treated cells, seven vehicle-treated cells and five photobleaching-control cells, sampled from at least four separate cultures. The overall comparison across the groups used a one-way analysis of variance and gave P=0.004. That is the reported overall test, not a separate P value for each pair. These small assay-specific samples should be kept distinct from the cell counts used for the earlier growth measurements. The reporter adds functional evidence, but does not directly measure normal dopamine transmission between neurons.
An acute calcitriol exposure did not produce a significant release effect. The main text and figure caption give different P values for that acute comparison, but both are nonsignificant. The chronic-versus-acute difference suggests that exposure timing matters. It does not establish which developmental change causes the later release result, nor that amphetamine-evoked reporter behaviour is identical to normal electrical transmission across a functioning neural network.
What could and could not be verified
The complete main paper and all four principal figures were examined. Its supporting file, containing additional diagrams, checks and primer information, was not accessible during this appraisal. Essential exposure protocols and principal outcomes are described in the main paper, so the account is restricted to those verifiable results. Additional uptake and receptor-correlation checks mentioned by the authors are not treated as independently inspected supplementary data.
This access limit matters for technical replication: the exact primer sequences used to measure gene transcripts and the full supporting image-analysis material could not be checked. Other limitations are visible in the principal report, including the engineered receptor system, lack of external authentication of that cell line and small culture-level replication. Adjusting statistical comparisons can address some sources of false positive results, but does not make cells from the same culture independent experimental replications.
Neural maintenance: calcium regulation in a separate model
Brewer and colleagues examined cultured embryonic rat hippocampal neurons in 2001. Calcitriol pretreatment improved survival after selected excitotoxic challenges, meaning damage associated with excessive excitatory signalling, at lower tested concentrations; the highest concentrations were not protective. They also used patch-clamp recording, which measures electrical ion currents across a small area of the cell membrane. At 50 nanomolar, the recorded L-type calcium-channel current was lower, whereas at 500 nanomolar it was higher. These channels provide one route for calcium entry. Changes in channel transcripts and currents occurred alongside protection, but the experiments did not establish that the channel change caused the survival benefit.
For one concrete comparison, the investigators assessed survival twenty-four hours after a complete medium exchange that stressed the cultures. About 5% of neurons receiving the matched solvent without calcitriol survived, compared with about 50% after pretreatment with 5 or 50 nanomolar calcitriol. This experiment used fifteen to eighteen culture wells per group; the reported comparison was statistically significant at P<0.001. The medium-exchange challenge should not be confused with the study’s separate experiments that directly added excitatory chemicals.
This addresses one component of neural maintenance: preserving cellular stability under a controlled challenge. The electrical measurements test channel function directly, while the change in direction at the higher concentration argues against assuming that more exposure must produce more benefit. These are culture concentrations, not recommended blood targets or supplement doses. The study does not establish long-term maintenance of an intact ageing brain or improved memory in adults.
The hippocampal experiment used blinded survival scoring, multiple injury protocols and matched solvent controls. Treatment before an imposed injury, however, does not establish rescue after a disease has developed. Calcium-channel regulation is one possible route among several, and the authors also discuss the importance of excitatory NMDA receptors, another route through which excessive signalling can injure neurons. A decisive test of mediation would alter the proposed route specifically and determine whether protection remains, rather than infer causation from parallel responses.
How these findings fit without overstating them
These papers answer three bounded questions. Human histology identifies possible sites of action. Developing-cell experiments show selected changes in shape, transmitter handling and reporter behaviour. Hippocampal cultures demonstrate exposure-dependent changes relevant to cellular stability. The studies do not form a single longitudinal experiment following vitamin D exposure from human fetal development through adult cognitive performance.
The links with inflammatory signalling and oxidative stress provide neighbouring physiological context. Neither pathway should be inserted as the demonstrated mediator of every result here. A reduction in vulnerability during one challenge, a change in dopamine handling and an altered inflammatory response are distinct observations. Explaining their possible relationships requires experiments that measure and perturb the proposed connections.
Within the evidence hierarchy, the appropriate conclusion is that vitamin D-related signalling has experimentally testable roles in neural biology. The evidence does not establish that supplementation improves development, preserves adult cognition or prevents a neurological disorder. Future work needs independent replication, clearer separation of culture-level and cell-level observations, direct tests of mechanism, and human studies suited to the clinical question being asked.
Scientific sources
Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain. Journal of Chemical Neuroanatomy. 2005;29:21 to 30. DOI: 10.1016/j.jchemneu.2004.08.006. PMID: 15589699. The complete published paper, seven figures and Table 1 were examined.
Pertile RAN, Brigden R, Raman V, Cui X, Du Z, Eyles D. Vitamin D: A potent regulator of dopaminergic neuron differentiation and function. Journal of Neurochemistry. 2023;166:779 to 789. DOI: 10.1111/jnc.15829. PMID: 37084159. The complete main paper and four figures were examined; the supplementary file was inaccessible and was not treated as independently verified.
Brewer LD, Thibault V, Chen K-C, Langub MC, Landfield PW, Porter NM. Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons. Journal of Neuroscience. 2001;21:98 to 108. DOI: 10.1523/JNEUROSCI.21-01-00098.2001. PMID: 11150325. The complete paper and seven figures were examined.
Related reading
Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation
In this study, we evaluated the potential of very early intervention with the active form of vitamin D (1,25-dihydroxyvitamin D3) to control neuroinflammation during EAE development.
Original paper ↗Read more →From armed-conflict to care: clinical outcomes, diagnostic challenges, and psychosocial burden in children evaluated for suspected cancer displaced from Gaza and treated at a regional center of excellence
Categorical variables were compared between groups using Fisher’s exact test; continuous variables using the Mann: Whitney U test.
Original paper ↗Read more →Is There Reduced Hemodynamic Brain Activation in Multiple Sclerosis Even with Undisturbed Cognition?
Eighteen participants with relapsing-remitting multiple sclerosis (RRMS) and fifteen healthy controls participated in this study.
Original paper ↗Read more →Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
We investigated the relationship of the Syntax Score (SS) and coronary artery calcification (CAC), with plasma levels of biomarkers related to cardiovascular damage and mineral metabolism, as there is sparse information in this field.
Original paper ↗Read more →The Association of Vitamin D, Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), and Glial Cell-Derived Neurotrophic Factor (GDNF) with Development in Children
Background: Short stature remains a global problem and is associated with vitamin D status.
Original paper ↗Read more →The Role of Vitamin D in Brain Health: A Mini Literature Review
Vitamin D is vital for our body as it regulates calcium homeostasis and maintains bone integrity.
Original paper ↗Read more →Vitamin D: Brain and Behavior
As a result, vitamin D can now confidently take its place among all other steroids known to regulate brain development.( 2 ) Others have concentrated on the possible neuroprotective functions of vitamin D in adult brains.
Original paper ↗Read more →Vitamin D Signalling in Brain Development and Regional Function: Study Summary
A concise explanation of vitamin D receptors, developing neurons and regional brain function, with the limits of tissue mapping and laboratory evidence.
Read more →Calcitriol confers neuroprotective effects in traumatic brain injury by activating Nrf2 signaling through an autophagy-mediated mechanism
The present study aimed to further explore the potential interaction between oxidative stress and autophagy in the progression of traumatic brain injury (TBI) and therapeutic mechanism of calcitriol, the active form of vitamin D (VitD).
Original paper ↗Read more →Brain region-dependent gene networks associated with selective breeding for increased voluntary wheel-running behavior
The cerebellum and striatum from a high voluntary running line and a non-selected control line were compared.
Original paper ↗Read more →Fatty fish intake and cognitive function: FINS-KIDS, a randomized controlled trial in preschool children
The purpose of the trial was to investigate whether an increased intake of fatty fish compared to meat improves cognitive function in children 4 to 6 years old.
Original paper ↗Read more →Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
The amyloid β (Aβ)-peptide, its amyloid precursor protein (APP) and the intermediate APP-c-terminal fragments (APP-CTFs) are all important players in AD pathogenesis.
Original paper ↗Read more →Parkinson’s disease-associated alterations in DNA methylation and hydroxymethylation in human brain
Epigenetic mechanisms mediate interactions between aging, genetics, and environmental factors in sporadic Parkinson’s disease (PD).
Original paper ↗Read more →Vitamin D and Brain
Discover how vitamin D supports brain function by influencing neural signalling, immune: brain communication, and regulatory pathways that help maintain neurological balance over time.
Read more →Neurochemical Effects of Chronic Administration of Calcitriol in Rats
Despite accumulating data showing the various neurological actions of vitamin D (VD), its effects on brain neurochemistry are still far from fully understood.
Original paper ↗Read more →Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1
Vitamin D deficiency (hypovitaminosis D) causes osteomalacia and poor long bone mineralization.
Original paper ↗Read more →Calcitriol Protects against Acetaminophen-Induced Hepatotoxicity in Mice
Our objective was to explore the protective role of calcitriol (VD3) in acute APAP-induced liver injury.
Original paper ↗Read more →Effects of vitamin D deficiency on neurobehavioural outcomes in children: a systematic review
We aimed to estimate the effects of vitamin D deficiency on neurobehavioural outcomes in children up to 18 years of age.
Original paper ↗Read more →Maternal Vitamin D Status and Infant Outcomes in Rural Vietnam: A Prospective Cohort Study
A prospective cohort study of 960 women who had previously participated in a double-blind cluster randomized controlled trial of antenatal micronutrient supplementation in rural Vietnam was undertaken.
Original paper ↗Read more →Midwives and public health nurses' knowledge and clinical practice in securing sufficient iodine status in relation to pregnancy: A cross‐sectional study
Around half of the participants provided dietary guidance to a great extent.
Original paper ↗Read more →The distribution of dietary choline intake and serum choline levels in Australian women during pregnancy and associated early life factors
Maternal dietary choline has a central role in foetal brain development and may be associated with later cognitive function.
Original paper ↗Read more →Original sources
Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain
Published in Journal of Chemical Neuroanatomy (2005).
Publication details
Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain. Journal of Chemical Neuroanatomy. 2005;29:21 to 30. DOI: 10.1016/j.jchemneu.2004.08.006. PMID: 15589699. The complete published paper, seven figures and Table 1 were examined.
Vitamin D: A potent regulator of dopaminergic neuron differentiation and function
Published in Journal of Neurochemistry (2023).
Publication details
Pertile RAN, Brigden R, Raman V, Cui X, Du Z, Eyles D. Vitamin D: A potent regulator of dopaminergic neuron differentiation and function. Journal of Neurochemistry. 2023;166:779 to 789. DOI: 10.1111/jnc.15829. PMID: 37084159. The complete main paper and four figures were examined; the supplementary file was inaccessible and was not treated as independently verified.
Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons
Published in Journal of Neuroscience (2001).
Publication details
Brewer LD, Thibault V, Chen K-C, Langub MC, Landfield PW, Porter NM. Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons. Journal of Neuroscience. 2001;21:98 to 108. DOI: 10.1523/JNEUROSCI.21-01-00098.2001. PMID: 11150325. The complete paper and seven figures were examined.